Loss of ACSS2 suppresses tumor development in certain mouse liver cancer models, including c-Myc expression combined with PTEN knockout in the liver (Alb-c-Myc; Alb-Cre; Ptenlox/lox). This evidence concerns the gene ACSS2 and liver cancer.